Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetminco Regulatory News (MNC)

  • There is currently no data for MNC

Convertible Note Facility

3 Apr 2017 07:00

RNS Number : 2820B
Metminco Limited
03 April 2017
 

ASX ANNOUNCEMENT

3 April 2017

 

METMINCO ANNCOUNCES A$0.75 MILLION CONVERTIBLE NOTE FOR COLOMBIAN GOLD FEASIBILITY STUDY

 

 

Metminco Limited (Metminco or the Company) (ASX: MNC; AIM: MNC) is pleased to announce that the Company has signed a binding term sheet with Redfield Asset Management and Redfield Advisory (together Redfield) in relation to a convertible note facility of A$0.75 million (the Convertible Notes) (the Transaction). The Convertible Notes are unsecured, unsubordinated, and are fully underwritten by Redfield, which is a strong supporter of the Company with an 8.62% shareholding in the Company. Lanstead Capital LP, which has a funding facility with the Company in place, has consented to this Convertible Notes transaction as set out in the binding term sheet.

 

Use of Funds

The proceeds from the Convertible Notes will be applied toward the Miraflores Gold Project Feasibility Study and working capital. The Feasibility Study, which is anticipated to be completed by the end of May 2017, is targeting annual gold production averaging 50,000 ozs/Au per annum for 9 years with estimated all in sustaining costs of US$650 per oz (refer the Company's announcement dated 8 September 2016).

 

The Miraflores Gold Project is part of the wider 100% Company owned Quinchia Gold Portfolio which includes the Tesorito, Dosquebradas and Chuscal gold targets, all of which have the potential to increase targeted mine life and annual gold production.

 

Key Terms of the Convertible Note

The key terms of the note are as follows:

Face Value:

A$750,000

Coupon Rate:

12.5% per annum, compounded monthly interest to be capitalised.

Conversion:

No later than 12 months from date of issue at which time the Convertible Notes and capitalised interest automatically convert to fully paid ordinary shares (Shares) at the Conversion Price.

At all times, conversion must be of all Convertible Notes and not some only.

Conversion Price

A$0.06075.

Options Granted:

i) 12,345,639 exercisable at A$0.081 per Share any time prior to 24 months from date of issue.

ii) 12,345,639 exercisable at A$0.081 per Share any time prior to 24 months from date of issue to be issued as soon as the Company's available placement capacity under ASX Listing Rule 7.1 is refreshed.

Funding:

A$100,000 to be received by the Company on 3 April 2017, and the remainder to be received in tranches, A$100,000 on 7 April 2017, A$100,000 on 17 April 2017 and the remainder expected to be received on 24 April 2017 but in any case no later than 12 May 2017 subject to limited due diligence and long form documentation.

Underwriting Fee:

4.5% of Face Value.

 

Should Redfield elect, under the terms of the Convertible Notes, to convert the principal amounts into Metminco shares at an assumed price A$0.06075, the holdings of the Redfield would be increased from 10,970,464 Shares (8.62%) to 23,316,143 Shares (16.71%).

This above figures assume that no other ordinary share issues are made by Metminco and that interest on the Convertible Notes is not capitalised. Redfield is ultimately controlled by its directors, including Mr Ram Venkat who is also a director of Metminco, and therefore is a "Related Party" under the AIM Rules. Consequently, the Transaction is considered to be a Related Party Transaction under AIM Rule 13.

With the exception of Mr Venkat, who through his position as a director of both Redfield and Metminco is involved in the transaction as a related party and who has absented himself from all discussions with Redfield in relation to this Convertible Notes facility, the Company's directors consider, having consulted with its nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned.

 

Mr Gaelan Bloomfield, Director of Redfield commented

"Redfield is a committed, long term investor in Metminco and will continue to support the Company as it transitions toward becoming a gold producer. We see further upside through nearby targets such as Tesorito, Dosquebradas and Chuscal which have the potential to further significantly enhance shareholder value".

 

 

Mr William Howe, Managing Director, commented

"In providing this funding Redfield has demonstrated its strong commitment to and belief in the Company. We are grateful for Redfields' continued support as we progress our Quinchia Gold Portfolio toward gold production.

The Miraflores Feasibility Study is on target to be completed by the end of May 2017 with submission of the EIA expected by the end of the year. Currently gold production is anticipated to be early 2019".

 

 

 

 

William Howe

Managing Director

 

 

 

 

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 ("MAR").

 

 

 

 

 

Metminco Limited ABN 43 119 759 349

ASX Code: MNC.AX; AIM Code: MNC.L

 

Suite 401, 6 Help Street, Chatswood NSW, 2067

Tel: +61 (0) 2 9460 1856; Fax: +61 (0) 2 9460 1857

www.metminco.com.au

 

 

For further information, please contact:

METMINCO LIMITED

 

 

Phil Killen

 

Office: +61 (0) 2 9460 1856

 

 

 

NOMINATED ADVISOR AND BROKER

 

 

RFC Ambrian

 

 

Australia

 

 

Will Souter / Nathan Forsyth

 

Office: +61 (0) 2 9250 0000

 

 

 

United Kingdom

 

 

Charlie Cryer

 

Office: +44 (0) 20 3440 6800

 

 

 

JOINT BROKER

 

 

SP Angel Corporate Finance LLP (UK)

 

 

Ewan Leggat

 

Office: +44 (0) 20 3470 0470

 

 

 

PUBLIC RELATIONS

 

 

Camarco

United Kingdom

 

 

Gordon Poole / Tom Huddart

 

Office: + 44 (0) 20 3757 4997

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUOUVRBBASRRR
Date   Source Headline
1st Feb 20187:00 amRNSDec 17 Quarterly Report inc App 5B
29th Jan 20187:00 amRNSPlan of Works Submission
25th Jan 20187:00 amRNSNotice of Extraordinary General Meeting
28th Dec 20177:00 amRNSChange in substantial shareholding
11th Dec 20177:00 amRNSAppointment/Resignation of Company Secretary
27th Nov 20177:00 amRNSMaiden Ore Reserve for Miraflores - Update
31st Oct 20177:00 amRNSSep 17 Quarterly Activities Report & Appendix 5B
30th Oct 20177:00 amRNSMiraflores Feasibility Study Release
18th Oct 20177:00 amRNSPositive Findings For Miraflores Feasibility Study
18th Oct 20177:00 amRNSMaiden Ore Reserve for Miraflores
10th Oct 20177:00 amRNSDirector/PDMR Transaction
4th Oct 20177:00 amRNSMetminco Completes Small Holdings Buyback
14th Sep 20177:00 amRNSApproval for Underground Development at Miraflores
13th Sep 20179:02 amRNSHalf Year Results
31st Aug 20177:00 amRNSExpiry of Unlisted Options
3rd Aug 20177:00 amRNSChairman resignation
1st Aug 20177:00 amRNSJune 17 Quarterly Activities Report & Appendix 5B
21st Jul 20174:40 pmRNSSecond Price Monitoring Extn
21st Jul 20174:35 pmRNSPrice Monitoring Extension
14th Jul 20177:31 amRNSSenior Management Change
14th Jul 20177:00 amRNSSale of Small Holdings
27th Jun 20177:42 amRNSSale of Interest in the Los Calatos Project
14th Jun 20177:32 amRNSChange in Holdings of Significant Shareholder
14th Jun 20177:00 amRNSSale of Interest Los Calatos to Release US$5M
14th Jun 20177:00 amRNSInvestor Q&A - Sale of Los Calatos
30th May 20177:00 amRNSAnnouncement Amendment - Additional Disclosure
23rd May 20177:01 amRNS2016 Annual General Meeting - Results
22nd May 20177:00 amRNSFunding Update
8th May 20177:00 amRNSIn Specie Distribution Update
2nd May 20177:02 amRNSMarch 17 Quarterly Activities Report & Appendix 5B
24th Apr 20177:00 amRNSNotice of AGM and Annual Report
3rd Apr 20177:00 amRNSFinancial Report - 31 December 2016
3rd Apr 20177:00 amRNSConvertible Note Facility
31st Mar 20177:00 amRNSAppendix 3X
20th Mar 20177:00 amRNSAppointment of Non-Executive Director
14th Mar 20177:00 amRNSMiraflores Resource Statement
14th Feb 20177:00 amRNSChange in significant shareholder
8th Feb 20179:16 amRNSChange in Substantial Shareholder
1st Feb 20177:00 amRNSChange of Directors Interest (Appendix 3Y)
1st Feb 20177:00 amRNSQuarterly Report & Appendix 5B - December 2016
1st Feb 20177:00 amRNSAppendix 3B
1st Feb 20177:00 amRNSCompletion of A$4.85 Million Capital Raising
4th Jan 20177:30 amRNSRestoration - Metminco Limited
3rd Jan 20179:16 amRNSShare Consolidation Complete
23rd Dec 20167:30 amRNSSuspension - Metminco Limited
23rd Dec 20167:00 amRNSInvestor Q&A
23rd Dec 20167:00 amRNSShare consolidation - suspension
20th Dec 20167:00 amRNSResults of Shareholder Meeting
19th Dec 20167:00 amRNSShare consolidation
15th Dec 20167:00 amRNSPlacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.